Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Loos

Showing results (81-90 of 215) with videos related to

Pageof 22
Sort By:
Anti-Cancer Drugs|December 29, 2000
Gender-dependent pharmacokinetics of topotecan in adult patientsW J Loos, H J Gelderblom, J Verweij, et al.
Anti-Cancer Drugs|December 1, 2005
Quantification of [3H]docetaxel in feces and urine: development and validation of a combustion methodFrederike K Engels, Dirk Buijs, Walter J Loos, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 21, 2000
Measurement of fraction unbound paclitaxel in human plasmaE Brouwer, J Verweij, P De Bruijn, et al.
Anti-Cancer Drugs|July 27, 2000
Inter-relationships of paclitaxel disposition, infusion duration and cremophor EL kinetics in cancer patientsL van Zuylen, L Gianni, J Verweij, et al.
British Journal of Cancer|July 11, 2002
Irinotecan pharmacokinetics-pharmacodynamics: the clinical relevance of prolonged exposure to SN-38R H J Mathijssen, J Verweij, W J Loos, et al.
Cancer Biology & Therapy|June 16, 2006
Influence of high-dose ketoconazole on the pharmacokinetics of docetaxelFrederike K Engels, Ron A A Mathot, Walter J Loos, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 22, 2011
Drug transporters of platinum-based anticancer agents and their clinical significanceHerman Burger, Walter J Loos, Karel Eechoute, et al.
Analytical Biochemistry|August 26, 1998
Linearized colorimetric assay for cremophor EL: application to pharmacokinetics after 1-hour paclitaxel infusionsE Brouwer, J Verweij, B Hauns, et al.
Cancer Biology & Therapy|September 14, 2006
Hepatic transport, metabolism and biliary excretion of irinotecan in a cancer patient with an external bile drainFloris A de Jong, Jos J E M Kitzen, Peter de Bruijn, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2007
Influence of ketoconazole on the fecal and urinary disposition of docetaxelFrederike K Engels, Walter J Loos, Ron A A Mathot, et al.
Pageof 22

Showing results (81-90 of 215) with videos related to

Sort By:
Pageof 22
Anti-Cancer Drugs|December 29, 2000
Gender-dependent pharmacokinetics of topotecan in adult patientsW J Loos, H J Gelderblom, J Verweij, et al.
Anti-Cancer Drugs|December 1, 2005
Quantification of [3H]docetaxel in feces and urine: development and validation of a combustion methodFrederike K Engels, Dirk Buijs, Walter J Loos, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 21, 2000
Measurement of fraction unbound paclitaxel in human plasmaE Brouwer, J Verweij, P De Bruijn, et al.
Anti-Cancer Drugs|July 27, 2000
Inter-relationships of paclitaxel disposition, infusion duration and cremophor EL kinetics in cancer patientsL van Zuylen, L Gianni, J Verweij, et al.
British Journal of Cancer|July 11, 2002
Irinotecan pharmacokinetics-pharmacodynamics: the clinical relevance of prolonged exposure to SN-38R H J Mathijssen, J Verweij, W J Loos, et al.
Cancer Biology & Therapy|June 16, 2006
Influence of high-dose ketoconazole on the pharmacokinetics of docetaxelFrederike K Engels, Ron A A Mathot, Walter J Loos, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 22, 2011
Drug transporters of platinum-based anticancer agents and their clinical significanceHerman Burger, Walter J Loos, Karel Eechoute, et al.
Analytical Biochemistry|August 26, 1998
Linearized colorimetric assay for cremophor EL: application to pharmacokinetics after 1-hour paclitaxel infusionsE Brouwer, J Verweij, B Hauns, et al.
Cancer Biology & Therapy|September 14, 2006
Hepatic transport, metabolism and biliary excretion of irinotecan in a cancer patient with an external bile drainFloris A de Jong, Jos J E M Kitzen, Peter de Bruijn, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2007
Influence of ketoconazole on the fecal and urinary disposition of docetaxelFrederike K Engels, Walter J Loos, Ron A A Mathot, et al.
Pageof 22